Isonics Corporation

Isonics Corporation offers homeland security products, security services, reclamation services, wafer thinning, and custom wafer products and services for the silicon industry. The company has three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The Homeland Security and Defense division focuses on developing solutions to protect and secure the assets and resources of clients. The Semiconductor division specializes in high quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services with a focus on the 300mm market. The Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. It offers security services for businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries. Isonics Corporation was formerly known as A&R Materials, Inc. and changed its name to Isonics Corporation in September 1996. The company was founded in 1992 and is based in Golden, Colorado.

Isonics Corporation trades as ISON on OTC. The company is classified in Industrials / Specialty Business Services and reports in USD.

The current profile places the business in Specialty Business Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $22.16M of revenue and -$11.77M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Isonics Corporation can be compared against peers such as Autoco.com, Inc., Britannia Bulk Holdings Inc., BlackPoll Fleet International, Inc., Celadon Group, Inc., EAU Technologies, Inc., Electronic Control Security Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $28, beta of -441.99, and return on equity of +233.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ISON currently shows total debt of $14.68M and beta of -441.99. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website is not available.

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.